| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Mar―12 |
From intestinal metabolites to the brain: Investigating the mysteries of Long COVID |
Shan Liu, Ashwarya S. Devason, Maayan Levy |
| 2 |
[GO] |
2024―Feb―15 |
A Chinese herbal formula Kesuting Syrup against COVID-19: Leveraging multidimensional computations in network pharmacology-driven experimental and clinical trials |
Cheng Zhang, Tian-Tian Sun, Ying Lv, Xing Li, Yun Ling, Ning Wang, Wen Xia, Xiaohong Fan, Yibin Feng |
| 3 |
[GO] |
2024―Jan―27 |
Letter to the Editor with # CTM2-2023-10-2488 entitled ‘Antibody responses as correlates of protection against SARS-CoV-2 in the Omicron era: A 5-month prospective cohort study in Korean healthcare workers’ |
So Yun Lim, Jineui Kim, Ji-Soo Kwon, Sung-Woon Kang, Seung-Beom Kim, Woori Kim, Ju Yeon Son, Choi Young Jang, Heedo Park, Jeonghun Kim, Sohyun Lee, Kyung Taek Kim, Jaeuk Choi, Ji Yeun Kim, Joon Seo Lim, Euijin Chang, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Man-Seong Park, Sung-Han Kim |
| 4 |
[GO] |
2024―Jan―15 |
The roles of innate and adaptive immunity in inactivated viral vaccination-mediated protection against COVID-19 |
Shanhe Yu, Shijun Chen, Jiang Zhu, Jieming Qu |
| 5 |
[GO] |
2023―Dec―14 |
Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China |
Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, Xiaohui Jia, Xiaolan Fu, Hui Guo, Min Jiao |
| 6 |
[GO] |
2023―Dec―08 |
Learning from the past? How biased memories of the pandemic endanger preparation for future crises |
Philipp Sprengholz, Luca Henkel, Robert Böhm, Cornelia Betsch |
| 7 |
[GO] |
2023―Nov―10 |
Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis |
Hu Meng, Arjun Sengupta, Emanuela Ricciotti, Antonijo Mrčela, Divij Mathew, Liudmila L. Mazaleuskaya, Soumita Ghosh, Thomas G. Brooks, Alexandra P. Turner, Alessa Soares Schanoski, Nicholas F. Lahens, Ai Wen Tan, Ashley Woolfork, Greg Grant, Katalin Susztak, Andrew G. Letizia, Stuart C. Sealfon, E. John Wherry, Krzysztof Laudanski, Aalim M. Weljie, Nuala J. Meyer, Garret A. FitzGerald |
| 8 |
[GO] |
2023―Nov―06 |
Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing |
Euijin Chang, Jungmin Lee, Jun-Won Kim, Jong Hyeon Seok, Joon-Yong Bae, Jeonghun Kim, Heedo Park, Choi-Young Jang, Sung-Woon Kang, So Yun Lim, Ji Yeun Kim, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee, Man-Seong Park, Sung-Han Kim |
| 9 |
[GO] |
2023―Oct―30 |
Polymerised type I collagen modifies the physiological network of post-acute sequelae of COVID-19 depending on sex: a randomised clinical trial |
Janette Furuzawa-Carballeda, Paola Vanessa Olguín-Rodríguez, Gonzalo Torres-Villalobos, Antonio Barajas-Martínez, Vania Jocelyn Martínez-Garcés, Ruben Fossion, Marco Antonio Martínez-Rivera, Elizabeth Ibarra-Coronado, Geraldine Tello-Santoyo, Octavio Abraham Bureos Lecona, Silvia Méndez-Flores, Kenia Ilian Rivas-Redonda, Eric Ochoa-Hein, Elizabeth Olivares-Martínez, Diego Francisco Hernández-Ramírez, Ana Leonor Rivera |
| 10 |
[GO] |
2023―Sep―11 |
COVID-19 vaccine hesitancy of older people in China |
Gewei Wang, Yao Yao, Yafeng Wang, Jinquan Gong, Qinqin Meng, Hui Wang, Wenjin Wang, Xinxin Chen, Yaohui Zhao |
| 11 |
[GO] |
2023―Aug―24 |
Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study |
Suad Hannawi, Rong-Rong Zhang, Alaa Abuquta, Linda Safeldin, Aala Hassan, Ahmad Alamadi, Tasmiah Hossain, Mohamed Mostafa, Yasser Ghoneim, Jennifer Solo, Hong-Xia Zheng, Ding-Feng Wu, Dan-Dan Yu, Jia-Cheng Yuan, Di Zhao, Rui Lin, Bo Ying, Cheng-Feng Qin |
| 12 |
[GO] |
2023―Jun―08 |
Development and validation of a novel CD4+ T cell-related gene signature to detect severe COVID-19 |
Da-Wei Zhang, Fang Li, Yuan-Yuan Wei, Lei Hu, Su-Hong Chen, Ming-Ming Yang, Wen-Ting Zhang, Guang-He Fei |
| 13 |
[GO] |
2023―Jan―20 |
Heterogenous antibody and T-cell responses to SARS-CoV-2 mRNA vaccines among immunocompromised young people |
Liangjian Lu, Chang Yien Chan, Pauline P. L. Chan-Ng, Mya Than, Pamela S. Y. Tan, Lee Kean Lim, Sharon Teo, Perry YW Lau, Kar Hui Ng, Elizabeth Y. Ang, Sivaramakrishnan Venkatesh Karthik, Marion M. Aw, Paul A. Tambyah, Hui Kim Yap, Bee Wah Lee |
| 14 |
[GO] |
2023―Jan―19 |
Evaluation of vaccine effectiveness against SARS-CoV-2 variants by serological epitope profiling |
Cheng Li, Zhenlin Yang, Yanling Wu, Tianlei Ying |
| 15 |
[GO] |
2023―Jan―14 |
Impacts of delta and omicron variants on inactivated SARS-CoV-2 vaccine-induced T cell responses in patients with autoimmune diseases and healthy controls |
Shuyi Wang, Jin Li, Shuang Wang, Yujin Ye, Mengyuan Li, Yihao Liu, Binfeng Chen, Yimei Lai, Liubing Li, Lili Zhuang, Sui Peng, Niansheng Yang, Hui Zhang, Haipeng Xiao |
| 16 |
[GO] |
2023―Jan―07 |
Transcriptomic analysis for the retested positive COVID-19 patients with long-term persistent SARS-CoV-2 but without symptoms in Wuhan |
Cuidan Li, Liya Yue, Yingjiao Ju, Jie Wang, Hao Lu, Lin Li, Mengfan Chen, Chenyang Wang, Shuangshuang Li, Tao Liu, Sitong Liu, Tianyi Lu, Jing Wang, Xin Hu, Chunlai Jiang, Dongsheng Zhou, Fei Chen |
| 17 |
[GO] |
2022―Dec―20 |
Raman spectroscopic cellomics for the detection of SARS-CoV-2-associated neutrophil activation after TNF-α stimulation |
Aikaterini Pistiki, Franziska Hornung, Anja Silge, Anuradha Ramoji, Oleg Ryabchykov, Thomas W. Bocklitz, Karina Weber, Bettina Löffler, Jürgen Popp, Stefanie Deinhardt-Emmer |
| 18 |
[GO] |
2022―Nov―30 |
Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection |
Yinggang Che, Dongbo Jiang, Yong Zhang, Junqi Zhang, Tianqi Xu, Yuanjie Sun, Jiangjiang Fan, Jiawei Wang, Ning Chang, Yingtong Wu, Shuya Yang, Leidi Xu, Jiaqi Ding, Chenchen Hu, Yinan Huang, Jian Zhang, Kun Yang |
| 19 |
[GO] |
2022―Nov―17 |
When the clock ticks wrong with COVID-19 |
Silvana Papagerakis, Raed Said, Farinaz Ketabat, Razi Mahmood, Meenakshi Pundir, Liubov Lobanova, Greg Guenther, Giuseppe Pannone, Kerry Lavender, Blake R. McAlpin, Alain Moreau, Xiongbiao Chen, Petros Papagerakis |
| 20 |
[GO] |
2022―Nov―07 |
Comprehensive profiling of the human viral exposome in households containing an at-risk child with mitochondrial disease during the 2020-2021 COVID-19 pandemic |
Eliza M. Gordon-Lipkin, Christopher S. Marcum, Shannon Kruk, Elizabeth Thompson, Sophie E. M. Kelly, Heather Kalish, Lorenza Bellusci, Surender Khurana, Kaitlyn Sadtler, Peter J. McGuire |
| 21 |
[GO] |
2022―Nov―02 |
RNASeq profiling of COVID19-infected patients identified an EIF2AK2 inhibitor as a potent SARS-CoV-2 antiviral |
Sidharth Jain, Samantha Rego, Steven Park, Yiran Liu, Simone Parn, Kush Savsani, David S. Perlin, Sivanesan Dakshanamurthy |
| 22 |
[GO] |
2022―Oct―14 |
On the essentiality of the angiotensin converting enzyme 2 receptor for SARS-CoV-2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID-19 |
Luise Hassler, Josef Penninger, Daniel Batlle |
| 23 |
[GO] |
2022―Oct―10 |
Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19 |
Makoto Kurano, Koh Okamoto, Daisuke Jubishi, Hideki Hashimoto, Eri Sakai, Daisuke Saigusa, Kuniyuki Kano, Junken Aoki, Sohei Harada, Shu Okugawa, Kent Doi, Kyoji Moriya, Yutaka Yatomi |
| 24 |
[GO] |
2022―Oct―07 |
Single-cell co-expression analysis using computational machine learning reveals oxidative, immunopathologic, and myocardial responses for multi-organ failure in COVID-19 |
Cheng Zhang, Ning Wang, Guoming Chen, Guoyi Tang, Chiwing Tam, Hor-Yue Tan, Xiaoyu Xu, Yibin Feng |
| 25 |
[GO] |
2022―Sep―19 |
Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: A single-blind randomized controlled trial |
Hildur Arnardottir, Sven-Christian Pawelzik, Philip Sarajlic, Alessandro Quaranta, Johan Kolmert, Dorota Religa, Craig E. Wheelock, Magnus Bäck |
| 26 |
[GO] |
2022―Sep―14 |
Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity |
Tianyu Cao, Li Liu, Kelvin Kai-Wang To, Chun-Yu Lim, Runhong Zhou, Yue Ming, Ka-Yi Kwan, Sulan Yu, Chun-Yin Chan, Biao Zhou, Haode Huang, Yufei Mo, Zhenglong Du, Ruomei Gong, Luk-Tsz Yat, Ivan Fan-Ngai Hung, Anthony Raymond Tam, Wing-Kin To, Wai-Shing Leung, Thomas Shiu-Hong Chik, Owen Tak-Yin Tsang, Xiang Lin, You-qiang Song, Kwok-Yung Yuen, Zhiwei Chen |
| 27 |
[GO] |
2022―Sep―14 |
A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults |
Deyan Luo, Hongxing Pan, Peng He, Xiaolan Yang, Tao Li, Nianzhi Ning, Xin Fang, Wenjing Yu, Mingwei Wei, Hui Gao, Xin Wang, Hongjing Gu, Maodong Mei, Xinwang Li, Liangyan Zhang, Deyu Li, Chunrun Gao, Jinbang Gao, Guoqiang Fei, Ying Li, Yuguo Yang, Yi Xu, Wenjin Wei, Yansong Sun, Fengcai Zhu, Zhongyu Hu, Hui Wang |
| 28 |
[GO] |
2022―Aug―21 |
Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections |
Murad Alahdal, Eyad Elkord |
| 29 |
[GO] |
2022―Jul―22 |
The impact of
ACE2
and co-factors on SARS-CoV-2 infection in colorectal cancer |
Shuwei Li, Silu Chen, Qiuyuan Zhu, Shuai Ben, Fang Gao, Junyi Xin, Mulong Du, Haiyan Chu, Dongying Gu, Zhengdong Zhang, Meilin Wang |
| 30 |
[GO] |
2022―Jul―15 |
Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID-19 |
Nicholas J. Lynch, Andrew C. Y. Chan, Youssif M. Ali, Priyanka Khatri, Ifeoluwa E. Bamigbola, Gregory Demopulos, Muriel Paganessi, Alessandro Rambaldi, Wilhelm J. Schwaeble |
| 31 |
[GO] |
2022―Jul―15 |
Integrating plasma cell-free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID-19 at hospital admission |
Yong Bai, Fang Zheng, Tongda Zhang, Qiuhong Luo, Yuxue Luo, Ruilong Zhou, Yan Jin, Ying Shan, Jiehui Cheng, Zhimin Yang, Lingguo Li, Haiqiang Zhang, Yan Zhang, Jianhua Yin, Mingyan Fang, Dongsheng Chen, Fanjun Cheng, Xin Jin |
| 32 |
[GO] |
2022―Jul―09 |
LncRNAs harbouring regulatory motifs within repeat elements modulate immune response towards COVID-19 disease severity and clinical outcomes |
Partha Chattopadhyay, Pallavi Mishra, Kriti Khare, Aanchal Yadav, Priyanka Mehta, Sheeba Saifi, Aparna Swaminathan, Priti Devi, Shaista Parveen, Akansha Tyagi, Vinita Jha, Bansidhar Tarai, Sujeet Jha, Sandeep Budhiraja, Jitendra Narayan, Rajesh Pandey |
| 33 |
[GO] |
2022―Jul―09 |
Profiling of host entry factors in adults and fetuses for severe acute respiratory syndrome coronavirus-2 infection indicates its developmental regulation |
Shizhe Yu, Haoren Wang, Lin Zhang, Qiang Cai, Duo Ma, Jian Zhao, Mengfei Ma, Zhiyong Yu, Zongping Xia |
| 34 |
[GO] |
2022―Jul―09 |
Antigenic imprinting in SARS-CoV-2 |
S. Momsen Reincke, Harald Prüss, Ian A. Wilson, Jakob Kreye |
| 35 |
[GO] |
2022―Jun―13 |
Human-host transcriptomic analysis reveals unique early innate immune responses in different sub-phenotypes of COVID-19 |
Ranjeet Maurya, Uzma Shamim, Partha Chattopadhyay, Priyanka Mehta, Pallavi Mishra, Priti Devi, Aparna Swaminathan, Sheeba Saifi, Kriti Khare, Aanchal Yadav, Shaista Parveen, Pooja Sharma, Vivekanand A, Akansha Tyagi, Vinita Jha, Bansidhar Tarai, Sujeet Jha, Mohd Faruq, Sandeep Budhiraja, Rajesh Pandey |
| 36 |
[GO] |
2022―Jun―13 |
Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role |
Nathalie Garnier, Kato Pollet, Marie Fourcot, Morgan Caplan, Guillemette Marot, Julien Goutay, Julien Labreuche, Fabrice Soncin, Rabah Boukherroub, Didier Hober, Sabine Szunerits, Julien Poissy, Ilka Engelmann |
| 37 |
[GO] |
2022―Jun―13 |
Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence |
Zhongtian Qi, Jianbo Wu, Shibo Jiang |
| 38 |
[GO] |
2022―Jun―09 |
Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS-CoV-2 vaccine |
Xingli Xu, Yun Liao, Guorun Jiang, Weiguo Yao, Suqin Duan, Kang Xiao, Xuefeng Ding, Heng Zhao, Yujian Zhang, Aihua Zhang, Jingsi Yang, Yanchun Che, Jun Zhang, Fanfan Zhao, Xiaopin Ma, Zhimei Zhao, Pingfang Cui, Xiaolei Yang, Xiaorui Lin, Wei Cai, Jiao Yan, Zhenqing Yang, Heng Qiu, Jing Zhang, Lei Huang, Mingyun Shen, Guofeng Zhao, Li Yu, Dandan Li, Shengtao Fan, Ying Zhang, Lichun Wang, Licun He, Fei Dong, Wenbo Xu, Hangwen Li, Qihan Li |
| 39 |
[GO] |
2022―May―11 |
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study |
Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Karla Montalbán-Hernández, José Carlos Casalvilla-Dueñas, Marta Bergón-Gutierrez, Alejandro Pascual-Iglesias, Jaime Valentín Quiroga, Luis A. Aguirre, Rebeca Pérez de Diego, Carmen Vela-Olmo, Lissette López-Morejón, Alejandro Martín-Quirós, Álvaro del Balzo-Castillo, María A. Peinado-Quesada, Miguel A. García-Garrido, Laura Gómez-Lage, Carmen Herrero-Benito, Irene Llorente-Fernández, Gema Martín-Miguel, Margarita Torrejón, Carolina Cubillos-Zapata, Carlos del Fresno, José Avendaño-Ortiz, Eduardo López-Collazo |
| 40 |
[GO] |
2022―May―11 |
Pathogenicity of SARS-CoV-2 Omicron |
Hin Chu, Kwok-Yung Yuen |
| 41 |
[GO] |
2022―May―11 |
Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS |
María C. García-Hidalgo, Jessica González, Iván D. Benítez, Paola Carmona, Sally Santisteve, Anna Moncusí-Moix, Clara Gort-Paniello, Fátima Rodríguez-Jara, Marta Molinero, Manel Perez-Pons, Gerard Torres, Jesús Caballero, Carme Barberà, Ana P. Tedim, Raquel Almansa, Adrián Ceccato, Laia Fernández-Barat, Ricard Ferrer, Dario Garcia-Gasulla, Rosario Menéndez, Ana Motos, Oscar Peñuelas, Jordi Riera, Jesús F. Bermejo-Martin, Antoni Torres, Ferran Barbé, David de Gonzalo-Calvo |
| 42 |
[GO] |
2022―Apr―22 |
Breakthrough infections and waning immune responses with ChAdOx1 nCoV-19 or mRNA vaccine in healthcare workers |
So Yun Lim, Jiwon Jung, Ji Yeun Kim, Soonju Park, Ji-Soo Kwon, So Yeon Park, Sun-Kyung Kim, Young-Ju Lim, Eun Ok Kim, Seongman Bae, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Nakyung Lee, Kideok Kim, David Shum, Youngmee Jee, Sung-Han Kim |
| 43 |
[GO] |
2022―Apr―13 |
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response |
Alberto Pérez-Gómez, Carmen Gasca-Capote, Joana Vitallé, Francisco J. Ostos, Ana Serna-Gallego, María Trujillo-Rodríguez, Esperanza Muñoz-Muela, Teresa Giráldez-Pérez, Julia Praena-Segovia, María D. Navarro-Amuedo, María Paniagua-García, Manuel García-Gutiérrez, Manuela Aguilar-Guisado, Inmaculada Rivas-Jeremías, María Reyes Jiménez-León, Sara Bachiller, Alberto Fernández-Villar, Alexandre Pérez-González, Alicia Gutiérrez-Valencia, Mohammed Rafii-El-Idrissi Benhnia, Daniela Weiskopf, Alessandro Sette, Luis F. López-Cortés, Eva Poveda, Ezequiel Ruiz-Mateos |
| 44 |
[GO] |
2022―Apr―07 |
PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron |
Arpan Acharya, Anup S. Pathania, Kabita Pandey, Michellie Thurman, Kendra R. Vann, Tatiana G. Kutateladze, Kishore B. Challagundala, Donald L. Durden, Siddappa N. Byrareddy |
| 45 |
[GO] |
2022―Mar―17 |
Effect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID-19 |
Silvia Méndez-Flores, Ángel Priego-Ranero, Daniel Azamar-Llamas, Héctor Olvera-Prado, Kenia Ilian Rivas-Redonda, Eric Ochoa-Hein, Andric Perez-Ortiz, Mario E. Rendón-Macías, Estefano Rojas-Castañeda, Said Urbina-Terán, Luis Septién-Stute, Thierry Hernández-Gilsoul, Adrián Andrés Aguilar-Morgan, Dheni A. Fernández-Camargo, Elizabeth Olivares-Martínez, Diego F. Hernández-Ramírez, Gonzalo Torres-Villalobos, Janette Furuzawa-Carballeda |
| 46 |
[GO] |
2022―Feb―27 |
Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine |
Bin Ju, Bing Zhou, Shuo Song, Qing Fan, Xiangyang Ge, Haiyan Wang, Lin Cheng, Huimin Guo, Dan Shu, Lei Liu, Zheng Zhang |
| 47 |
[GO] |
2022―Feb―20 |
Zinc and vitamin C intake increases spike and neutralising antibody production following SARS-CoV-2 infection |
Amy May Lin Quek, Delicia Shu Qin Ooi, Ooiean Teng, Chang Yien Chan, Geelyn Jeng Lin Ng, Mei Yen Ng, Sidney Yee, Ee Wan Cheong, Ruifen Weng, Alex R. Cook, Mikael Hartman, Veronique Angeli, Paul Anantharajah Tambyah, Raymond Chee Seong Seet |
| 48 |
[GO] |
2022―Jan―27 |
T
FH
2 cells associate with enhanced humoral immunity to SARS-CoV-2 inactivated vaccine in patients with allergic rhinitis |
Yin Yao, Zhe-Zheng Wang, Ao Huang, Yan Liu, Nan Wang, Zhi-Chao Wang, Lin Yang, Hui-Jun Li, Jun-Gang Xie, Rong-Fei Zhu, Li-Ming Cheng, Di Yu, Zheng Liu |
| 49 |
[GO] |
2022―Jan―27 |
Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses |
Runhong Zhou, Kelvin Kai-Wang To, Qiaoli Peng, Jacky Man-Chun Chan, Haode Huang, Dawei Yang, Bosco Hoi-Shiu Lam, Vivien Wai-Man Chuang, Jian-Piao Cai, Na Liu, Ka-Kit Au, Owen Tak-Yin Tsang, Kwok-Yung Yuen, Zhiwei Chen |
| 50 |
[GO] |
2022―Jan―25 |
COVID-19 bimodal clinical and pathological phenotypes |
Sabrina S. Batah, Maíra N. Benatti, Li Siyuan, Wagner M. Telini, Jamile O. Barboza, Marcelo B. Menezes, Tales R. Nadai, Keyla S. G. Sá, Chirag M. Vaswani, Sahil Gupta, Dario S. Zamboni, Danilo T. Wada, Rodrigo T. Calado, Renê D. R. Oliveira, Paulo Louzada-Junior, Maria Auxiliadora-Martins, Flávio P. Veras, Larissa D. Cunha, Thiago M. Cunha, Rodrigo Luppino-Assad, Marcelo L. Balancin, Sirlei S. Morais, Ronaldo B. Martins, Eurico Arruda, Fernando Chahud, Marcel Koenigkam Santos, Andrea A. Cetlin, Fernando Q. Cunha, Claudia dos Santos, Vera L. Capelozzi, Junya Fukuoka, Rosane Duarte Achcar, Alexandre T. Fabro |
| 51 |
[GO] |
2022―Jan―25 |
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes |
Laia Reverté, Elena Yeregui, Montserrat Olona, Alicia Gutiérrez-Valencia, Maria José Buzón, Anna Martí, Frederic Gómez-Bertomeu, Teresa Auguet, Luis F. López-Cortés, Joaquin Burgos, Clara Benavent-Bofill, Carme Boqué, Graciano García-Pardo, Ezequiel Ruiz-Mateos, Maria Teresa Mestre, Francesc Vidal, Consuelo Viladés, Joaquim Peraire, Anna Rull |
| 52 |
[GO] |
2021―Dec―28 |
The volatile and heterogeneous gut microbiota shifts of COVID-19 patients over the course of a probiotics-assisted therapy |
Chunyan Wu, Qian Xu, Zhan Cao, Dengdeng Pan, Ying Zhu, Sheng Wang, Danping Liu, Zhigang Song, Wei Jiang, Yumeng Ruan, Yongkun Huang, Nan Qin, Hongzhou Lu, Huanlong Qin |
| 53 |
[GO] |
2021―Dec―19 |
Correlation of vaccine-elicited antibody levels and neutralizing activities against SARS-CoV-2 and its variants |
Jinbiao Liu, Brittany H Bodnar, Nigam H Padhiar, Adil I Khan, Fengzhen Meng, Sami Saribas, Peng Wang, Xu Wang, Elizabeth McCluskey, Sahil Shah, Huaqing Zhao, Jin Jun Luo, Wen-Hui Hu, Wen-Zhe Ho |
| 54 |
[GO] |
2021―Dec―15 |
ACEs family genes: Important molecular links between lung cancer and COVID-19 |
Yinjiang Zhang, Lu Fan, Rongfei Yao, Xu He, Linyi Zhao, Binan Lu, Zongran Pang |
| 55 |
[GO] |
2021―Dec―15 |
The omicron variant of SARS-CoV-2: Understanding the known and living with unknowns |
Nicholas E. Ingraham, David H. Ingbar |
| 56 |
[GO] |
2021―Dec―13 |
How to translate the knowledge of COVID-19 into the prevention of Omicron variants |
Xiangdong Wang, Charles A. Powell |
| 57 |
[GO] |
2021―Nov―04 |
The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID-19 |
Mingfeng Liao, Xuejiao Liao, Jing Yuan, Bing Zhou, Yang Liu, Xiao Jiang, Zhan Zhang, Caiping Guo, Yunjia Zhang, Shuye Zhang, Lei Liu, Zheng Zhang |
| 58 |
[GO] |
2021―Nov―04 |
SARS-CoV-2 infection in lung transplant recipients induces circulating exosomes with SARS-CoV-2 spike protein S2 |
Sandhya Bansal, Sofya Tokman, Timothy Fleming, Gabriel N. Maine, Kristina Sanborn, Ramsey Hachem, Ankit Bharat, Michael A. Smith, Ross M. Bremner, T. Mohanakumar |
| 59 |
[GO] |
2021―Oct―21 |
The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission |
José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, Verónica Terrón, Charbel Maroun-Eid, Karla Montalbán-Hernández, Jaime Valentín-Quiroga, Miguel Ángel García-Garrido, Elena Muñoz del Val, Álvaro del Balzo-Castillo, María Peinado, Laura Gómez, Carmen Herrero-Benito, Carolina Rubio, José Carlos Casalvilla-Dueñas, Paloma Gómez-Campelo, Alejandro Pascual-Iglesias, Carlos del Fresno, Luis A. Aguirre, Eduardo López-Collazo |
| 60 |
[GO] |
2021―Sep―27 |
Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID-19 |
Zhaoming Zhou, Xiang Zhou, Liming Cheng, Lei Wen, Taixue An, Heng Gao, Hongrong Deng, Qi Yan, Xinlu Zhang, Youjiang Li, Yixing Liao, Xin-zu Chen, Bin Nie, Jie Cheng, Guanhua Deng, Shengqiang Wang, Juan Li, Hanqi Yin, Mengxian Zhang, Linbo Cai, Lei Zheng, Minglun Li, Bleddyn Jones, Longhua Chen, Amir Abdollahi, Meijuan Zhou, Ping-Kun Zhou, Cheng Zhou |
| 61 |
[GO] |
2021―Sep―27 |
SARS-CoV-2 spike protein alleviates atherosclerosis by suppressing macrophage lipid uptake through regulating R-loop formation on MSR1 mRNA |
Wenting Zhao, Zhen Wang, Wenjing Chen, Miao Chen, Jie Han, Xiang Yin, Xiaotong Hu, Shuai Wang, Jie Zan, Liangrong Zheng |
| 62 |
[GO] |
2021―Sep―21 |
Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients |
Nitesh Kumar Singh, Surabhi Srivastava, Lamuk Zaveri, Thrilok Chander Bingi, Rajarao Mesipogu, Santosh Kumar V., Namami Gaur, Nikhil Hajirnis, Pratheusa Machha, Sakshi Shambhavi, Shagufta Khan, Mamilla Soujanya, Tulasi Nagabandi, Rakesh K. Mishra, Karthik Bharadwaj Tallapaka, Divya Tej Sowpati |
| 63 |
[GO] |
2021―May―22 |
Identification of potential vaccine targets for COVID-19 by combining single-cell and bulk TCR sequencing |
Pingping Wang, Zhaochun Xu, Wenyang Zhou, Xiyun Jin, Chang Xu, Meng Luo, Kexin Ma, Huimin Cao, Yan Huang, Xiaoyu Lin, Fenglan Pang, Yiqun Li, Qinghua Jiang |
| 64 |
[GO] |
2021―May―22 |
Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children |
Yue Tao, Ruwen Yang, Chen Wen, Jue Fan, Jing Ma, Qiao He, Zhiguang Zhao, Xinyu Song, Hao Chen, Guocheng Shi, Minzhi Yin, Nan Fang, Hao Zhang, Huiwen Chen, Xi Mo |
| 65 |
[GO] |
2021―Apr―04 |
Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19 |
Rita Valenzuela, Maria A. Pedrosa, Pablo Garrido-Gil, Carmen M. Labandeira, Gemma Navarro, Rafael Franco, Ana I. Rodriguez-Perez, Jose L. Labandeira-Garcia |
| 66 |
[GO] |
2021―Mar―24 |
Distinct kinetics of immunoglobulin isotypes reveal early diagnosis and disease severity of COVID-19: A 6-month follow-up |
Siyang Yu, Jianghong An, Xuejiao Liao, Haiyan Wang, Fen Ma, Dapeng Li, Aimin Li, Weilong Liu, Siwei Zhang, Mingfeng Liao, Lei Liu, Juanjuan Zhao, Shaojun Xing, Lanlan Wei, Zheng Zhang |
| 67 |
[GO] |
2021―Mar―01 |
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study |
Francesco Vieceli Dalla Sega, Francesca Fortini, Savino Spadaro, Luca Ronzoni, Ottavio Zucchetti, Marco Manfrini, Elisa Mikus, Alberto Fogagnolo, Francesca Torsani, Rita Pavasini, Luisa Marracino, Marco Verri, Luca Morandi, Emanuele D'Aniello, Carlo Alberto Volta, Gianluca Campo, Roberto Ferrari, Paola Rizzo, Marco Contoli |
| 68 |
[GO] |
2021―Feb―26 |
Accurate classification of COVID-19 patients with different severity via machine learning |
Chaoyang Sun, Yong Bai, Dongsheng Chen, Liang He, Jiacheng Zhu, Xiangning Ding, Lihua Luo, Yan Ren, Hui Xing, Xin Jin, Gang Chen |
| 69 |
[GO] |
2021―Feb―23 |
SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers |
Xue-Ping Li, Xin Huang, Yan-Mei Qin, Guo-Yan Wu, Cheng-Cai Liang, Yu-Jun Dai, Wei-Na Zhang |
| 70 |
[GO] |
2021―Feb―18 |
Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection |
Wei Xu, Shan Su, Shibo Jiang |
| 71 |
[GO] |
2021―Jan―27 |
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial |
Xiaowei Xu, Wanli Jiang, Lijun Chen, Zhenyu Xu, Qiang Zhang, Mengfei Zhu, Peng Ye, Hang Li, Liang Yu, Xiaoyang Zhou, Chenliang Zhou, Xiaobei Chen, Xiaoqin Zheng, Kaijin Xu, Hongliu Cai, Shufa Zheng, Wubian Jiang, Xiaojun Wu, Dong Li, Lu Chen, Qingqing Luo, Yingyan Wang, Jingjing Qu, Yifei Li, Wendi Zheng, Yingan Jiang, Lingling Tang, Charlie Xiang, Lanjuan Li |
| 72 |
[GO] |
2021―Jan―17 |
Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein |
Satish Sagar, Ashok Kumar Rathinavel, William E. Lutz, Lucas R. Struble, Surender Khurana, Andy T. Schnaubelt, Nitish Kumar Mishra, Chittibabu Guda, Nicholas Y. Palermo, Mara J. Broadhurst, Tobias Hoffmann, Kenneth W. Bayles, St. Patrick M. Reid, Gloria E. O. Borgstahl, Prakash Radhakrishnan |
| 73 |
[GO] |
2021―Jan―15 |
Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics |
Shan Su, Qian Wang, Shibo Jiang |
| 74 |
[GO] |
2021―Jan―02 |
Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes |
María P. Fernández-Pérez, Sonia Águila, Laura Reguilón-Gallego, Ascensión M. los Reyes-García, Antonia Miñano, Carlos Bravo-Pérez, María E. Morena, Javier Corral, Nuria García-Barberá, José M. Gómez-Verdú, Enrique Bernal, María T. Herranz, Vicente Vicente, Constantino Martínez, Rocío González-Conejero, María L. Lozano |
| 75 |
[GO] |
2020―Dec―22 |
Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis |
Weijun Jiang, Weiwei Li, Lei Xiong, Qiuyue Wu, Jian Wu, Bangshun He, Jiawei Shen, Rongrong Pang, Tao Luo, Yanju Guo, Yang Yang, Ying Han, Wei Dai, Peiran Zhu, Xinyi Xia |
| 76 |
[GO] |
2020―Dec―10 |
A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities |
Xiaofei Jiao, Ya Wang, Dan Liu, Shaoqing Zeng, Jianhua Chi, Ruyuan Li, Yang Yu, Ruidi Yu, Siyuan Wang, Yuan Yuan, Yue Gao, Sen Xu, Chunrui Li, Qinglei Gao |
| 77 |
[GO] |
2020―Nov―08 |
Buffer wards for the control of COVID-19 transmission in hospitals |
Wensi Zhao, Yi Gao, Qiuni Xu, Wanjun Ding, Dedong Cao, Zhuya Xiao, Jiayu Chen, Li Yan, Chen Zhao, Xiaoxu Li, Ying Chen, Qian Chen, Yongshun Chen |
| 78 |
[GO] |
2020―Nov―03 |
Persistent viral activity, cytokine storm, and lung fibrosis in a case of severe COVID-19 |
Gang Xu, Yang Liu, Mingfeng Liao, Jizhou Gou, Xin Wang, Jing Yuan, Weilong Liu, Guangde Zhou, Shuye Zhang, Lei Liu, Zheng Zhang |
| 79 |
[GO] |
2020―Oct―21 |
CIRPMC: An online model with simplified inflammatory signature to predict the occurrence of critical illness in patients with COVID-19 |
Yue Gao, Lingxi Chen, Shaoqing Zeng, Xikang Feng, JianHua Chi, Ya Wang, Huayi Li, Tengping Jiang, Yang Yu, XiaoFei Jiao, Dan Liu, XinXia Feng, SiYuan Wang, RuiDi Yu, Yuan Yuan, Sen Xu, Guangyao Cai, Xiaoming Xiong, Pingbo Chen, Qingqing Mo, Xin Jin, Yuan Wu, Ding Ma, Chunrui Li, Shuai Cheng Li, Qinglei Gao |
| 80 |
[GO] |
2020―Oct―18 |
Instantaneous “catch-and-kill” inactivation of SARS-CoV-2 by nitride ceramics |
Giuseppe Pezzotti, Eriko Ohgitani, Masaharu Shin-Ya, Tetsuya Adachi, Elia Marin, Francesco Boschetto, Wenliang Zhu, Osam Mazda |
| 81 |
[GO] |
2020―Oct―14 |
Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID-19 |
Jiansheng Huang, Hui Huang, Dongdong Wang, Chuan Wang, Youfa Wang |
| 82 |
[GO] |
2020―Oct―11 |
The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19 |
Hao Tang, Yuehan Gao, Zhaohuai Li, Yushan Miao, Zhaohao Huang, Xiuxing Liu, Lihui Xie, He Li, Wen Wen, Yingfeng Zheng, Wenru Su |
| 83 |
[GO] |
2020―Sep―16 |
Immunity-modulated sex disparity on COVID-19 prognosis |
Dan Liu, Jiahao Liu, Shaoqing Zeng, Ya Wang, Yuan Yuan, Sen Xu, Siyuan Wang, Ruidi Yu, Xinxia Feng, Huayi Li, Xiaofei Jiao, Jianhua Chi, Chunrui Li, Fei Ye, Qinglei Gao |
| 84 |
[GO] |
2020―Aug―22 |
COVID-19 diagnostic testing: Technology perspective |
Meng Xu, Dan Wang, Hongye Wang, Xiaomei Zhang, Te Liang, Jiayu Dai, Meng Li, Jiahui Zhang, Kai Zhang, Danke Xu, Xiaobo Yu |
| 85 |
[GO] |
2020―Jul―22 |
Alteration of serum markers in COVID-19 and implications on mortality |
Dan Liu, Ruyuan Li, Ruidi Yu, Ya Wang, Xinxia Feng, Yuan Yuan, Siyuan Wang, Shaoqing Zeng, Yue Gao, Sen Xu, Huayi Li, Xiaofei Jiao, Jianhua Chi, Yang Yu, Chunyan Song, Ning Jin, Pengfei Cui, Jiahao Liu, Xu Zheng, Wenjian Gong, Xingyu Liu, Guangyao Cai, Jianming Song, Susan Yuk-Lin Kwan, Aakash Desai, Chunrui Li, Qinglei Gao |
| 86 |
[GO] |
2020―Jun―11 |
Mental health and psychosocial function of general population during the COVID-19 epidemic in China |
Qi Zhou, Zhenyu Hu, Guolin Bian, Haihang Yu, Xingxing Li, Yin Lu, Chang Yu, Xianglan Li, Qin Yao, Wenhua Zhou, Ti-Fei Yuan, Dongsheng Zhou |
| 87 |
[GO] |
2020―Jun―09 |
Acute lung injury in patients with COVID-19 infection |
Liyang Li, Qihong Huang, Diane C. Wang, David H. Ingbar, Xiangdong Wang |
| 88 |
[GO] |
2020―Jun―09 |
Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports |
Linlin Zhang, Diane C. Wang, Qihong Huang, Xiangdong Wang |
| 89 |
[GO] |
2020―Jun―09 |
Collaborated effort against SARS-CoV-2 outbreak in China |
Qiwen Yang, Yang Zhou, Jingwen Ai, Jinmin Ma, Fenglin Cao, Weifan Cao, Wengeng Zhang, Shifu Wang, Weijun Chen, Xiaoling Ma, Wenhong Zhang, Weimin Li |
| 90 |
[GO] |
2020―Jun―09 |
Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? |
Yunbao Pan, Guangming Ye, Xiantao Zeng, Guohong Liu, Xiaojiao Zeng, Xianghu Jiang, Jin Zhao, Liangjun Chen, Shuang Guo, Qiaoling Deng, Xiaoyue Hong, Ying Yang, Yirong Li, Xinghuan Wang |
| 91 |
[GO] |
2020―Jun―08 |
A new and rapid approach for detecting COVID-19 based on S1 protein fragments |
Hua Li, Zhe Liu, Yue He, Yingjie Qi, Jie Chen, Yuanyuan Ma, Fujia Liu, Kaisheng Lai, Yong Zhang, Liu Jiang, Xiangdong Wang, Junbo Ge |
| 92 |
[GO] |
2020―Jun―08 |
COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis |
Hooman D. Poor, Corey E. Ventetuolo, Thomas Tolbert, Glen Chun, Gregory Serrao, Amanda Zeidman, Neha S. Dangayach, Jeffrey Olin, Roopa Kohli-Seth, Charles A. Powell |
| 93 |
[GO] |
2020―Jun―08 |
Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China |
Fuyang Chen, Wenwu Sun, Shengrong Sun, Zhiyu Li, Zhong Wang, Li Yu |
| 94 |
[GO] |
2020―Jun―08 |
Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients |
Zibo Meng, Dianyun Ren, Yun Liu, Xiaoming Lu, Wei Xiong, Xin Jin |
| 95 |
[GO] |
2020―Jun―08 |
Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China |
Chaomin Wu, Xianglin Hu, Jianxin Song, Dong Yang, Jie Xu, Kebin Cheng, Dechang Chen, Ming Zhong, Jinjun Jiang, Weining Xiong, Ke Lang, Yan Tao, Xiaoqin Lin, Guohua Shi, Liwen Lu, Longci Pan, Lei Xu, Xin Zhou, Yuanlin Song, Ming Wei, Junhua Zheng, Chunling Du |
| 96 |
[GO] |
2020―Jun―08 |
Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019 |
Chengshui Chen, Feng Qi, Keqing Shi, Yuping Li, Ji Li, Yongping Chen, Jingye Pan, Tieli Zhou, Xiangyang Lin, Jinsan Zhang, Yongde Luo, Xiaokun Li, Jinglin Xia |
| 97 |
[GO] |
2020―Feb―20 |
2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies |
Jun She, Jinjun Jiang, Ling Ye, Lijuan Hu, Chunxue Bai, Yuanlin Song |
|
